Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension - Wikidata - awgldk - TriplyDB

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

http://www.wikidata.org/entity/Q35850232

about

Targeting BMP signalling in cardiovascular disease and anaemia BMPR2 spruces up the endothelium in pulmonary hypertension Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension Subcellular mechanisms in pulmonary arterial hypertension: combinatorial modalities that inhibit anterograde trafficking and cause bone morphogenetic protein receptor type 2 mislocalization.Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.Bone Morphogenetic Protein (BMP) signaling in development and human diseases Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.BMP pathway regulation of and by macrophages.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload.Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension A potential role for insulin resistance in experimental pulmonary hypertension Gender, sex hormones and pulmonary hypertension.Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.A process-based review of mouse models of pulmonary hypertension.Differential regulation of translation and endocytosis of alternatively spliced forms of the type II bone morphogenetic protein (BMP) receptor Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Echocardiographic assessment of the right heart in mice.Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.Protein Expression by Human Pulmonary Artery Smooth Muscle Cells Containing a BMPR2 Mutation and the Action of ET-1 as Determined by Proteomic Mass Spectrometry.Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2+) Transients in Severe Pulmonary Arterial Hypertension.Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.Surfactant protein D (SP-D) deficiency is attenuated in humanised mice expressing the Met(11)Thr short nucleotide polymorphism of SP-D: implications for surfactant metabolism in the lung.Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension.Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling.

P2860

Q26783734-9C1D6D55-1DFD-4C1B-A6C4-663386840984 Q26786834-9CB931C9-0AA7-4857-8145-06421B51028D Q27009717-768DD4BE-2953-4087-98E7-0E094F1C1FCC Q33738642-A743BC84-5879-4C3A-87F5-A8013006743E Q33806083-C1AB2CC5-BE9C-47E4-B5DF-97D94F4D492C Q33806134-9316239F-C2BB-460D-A21D-62DDC1A35864 Q33959437-16106BD9-CFCC-4DEE-AD7E-C24F0DDB31CE Q34512444-574931E8-9954-478C-BA7F-F354B26E77F9 Q34576173-D53F1ABF-26FC-44D7-8B1D-98F59BF6C9B1 Q35019516-03BF7028-D409-48B1-8D0C-F07346130362 Q35142695-BA9B2343-0E30-48D7-88BF-A54C70460824 Q35410950-ECD8B49B-6F0D-483D-8630-36657A66DE72 Q35919662-47C7E1A9-B0E1-4E39-BE8A-F9BC4B2FA333 Q36352101-1E1AA423-3426-4222-B216-EB58C78CF5D7 Q36421287-07605121-B168-4C85-BCE9-E35B3A8D8B66 Q36480359-78B54662-2A50-4625-A2DF-1838755445A4 Q36623035-3A22217F-C017-4847-B765-BEF12B07E451 Q36847595-B93F544C-DA8C-499C-BF18-F3CA3C955F1F Q36908852-49A32826-D3D3-46F7-B554-6BA8EFC056E2 Q36943390-A0EA3B49-B5E1-4D74-B22B-FF428F0EB2F6 Q37104263-9812308C-EDD2-4850-91CC-CDC3AF27D759 Q37133789-0AC53813-668F-4DD8-887E-9037AADADBD3 Q37596437-DCA22099-5A52-49D2-A651-9548C9F6E1B3 Q37688533-5EA4FC0C-0861-4F78-8AAF-2BB913ACDDBB Q38078369-A2066C79-D195-4E50-965E-43F87C56BD74 Q38370151-0CDB0710-762D-4B9B-9941-7E70CB16AF69 Q38450447-90D07FE7-B1EF-42C2-AFBB-76859B1A77E1 Q38642429-5EC20591-29C8-4CE3-A81D-C4B8DEDD1009 Q38778327-5198D755-4124-418B-95BF-E5DD0E52B097 Q38779774-A08ACF03-767D-49EF-99B1-F9C654CF2D97 Q38833632-6BD211C1-A0D1-4F39-A79C-7E22C77FEDED Q39118942-0C42454C-09BF-4405-A1CF-835A5D979FF7 Q39313701-A6FB7720-0C52-4F2E-AD4A-441A3F47A7BD Q41841126-DCEFB7C3-D8FB-45D6-B202-C087C71E86AC Q42112003-C2F33C13-3D84-479A-8B16-7D672CFAB3B0 Q44765093-42FFB216-68DF-41E9-86F8-CFF994EE3832 Q46140026-3979A1A6-84A0-4166-8293-CB23C66A2860 Q46336560-7E737B35-7C9A-4112-907C-593F7D793A48 Q46516719-397648CF-4991-4E7F-8A35-59598D40B201 Q47141916-8AACCF5C-3527-484F-A803-53686C9DFD51

P2860

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

http://www.wikidata.org/entity/Q35850232

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@ast

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@en

type

label

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@ast

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@en

prefLabel

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@ast

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@en

P1433

Q35850232-BE7CC9BD-D1CD-4257-9D33-411B7AE81397

P1476

Q35850232-BC96CA2B-CB5B-4132-BD0A-0C653CD1D952

P2093

Q35850232-0F17CFFD-162E-4FE0-8331-C317063A3543

Q35850232-1CBD32D1-48AA-48C1-AE6B-A13A17D000C8

Q35850232-47D75782-D271-44BE-8FBD-9A8FA8D001E6

Q35850232-722F1C14-009C-491D-A9DF-EA55157891F4

Q35850232-84FC5EF8-8A0C-4142-AB20-E22C5B86F83F

Q35850232-96A7DCDD-E625-4F01-8A99-8C9C27D9C2B1

Q35850232-9717F961-CC63-43D7-A629-59D000B20C56

Q35850232-A12FA002-C2A2-4BB6-B1FC-F07FE9C30DCD

Q35850232-A5F330DC-2C72-46CA-8DA4-7B9B538B11E3

Q35850232-C2EE61C8-7F4B-434E-8E06-458B1393F1F6

P2860

Q35850232-0501F236-D5D2-46F1-A804-B2E6C2593EE5

Q35850232-114F9E86-68D8-4D16-9769-8A30EFEB7B0A

Q35850232-1517FA98-9349-4529-9B10-94CE1489B156

Q35850232-1710318B-4265-47AB-B8EB-2DF0D6988D50

Q35850232-1970D41D-455F-49B0-A88F-8DC43BA93487

Q35850232-1A760D67-CB3D-4585-A285-A39257107D36

Q35850232-1A9539B4-A2A8-47E8-A60B-77F9CD44CB7A

Q35850232-1E60947B-B1F9-4A50-9D29-AB67CED3A8B0

Q35850232-21698D66-723F-4091-89D2-1DC94EF1444B

Q35850232-2260F8D5-AAEF-4438-82E0-AB513124D1A4

P304

Q35850232-17FB726D-EC9E-4C90-BD1D-9D0325B6670F

P31

Q35850232-0249AB4D-7E82-4B32-9F85-81C20F27435F

P356

Q35850232-A44C8C9D-DB60-4303-9B9B-E3D5AE916D38

P433

Q35850232-23506503-E76A-4B0C-9E4D-8D1F6F1448CB

P478

Q35850232-DB56C82A-9B98-4248-B5DE-9BCAC6727411

P50

Q35850232-ED448178-E940-4F5D-B13C-CB9CC1B3AFEA

P577

Q35850232-3B18A141-D72C-4ED6-A72F-B181433EE2D7

P698

Q35850232-F5E13927-DE12-43C8-A4A7-639123F120FA

P921

Q35850232-D69BBD80-8484-4D97-BAD0-B63D1D41DF4A

P932

Q35850232-67ECAF28-E4EE-4A6A-B256-31D8C8E039FE

P356

AJPLUNG.00202.2011

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

@en

P2093

Anna R Hemnes

http://www.w3.org/2001/XMLSchema#string

Hans Loibner

http://www.w3.org/2001/XMLSchema#string

James West

http://www.w3.org/2001/XMLSchema#string

Jennifer A Johnson

http://www.w3.org/2001/XMLSchema#string

Julie W Harral

http://www.w3.org/2001/XMLSchema#string

Karen A Fagan

http://www.w3.org/2001/XMLSchema#string

Kirk B Lane

http://www.w3.org/2001/XMLSchema#string

Linda J Robinson

http://www.w3.org/2001/XMLSchema#string

Manfred Schuster

http://www.w3.org/2001/XMLSchema#string

Megha Talati

http://www.w3.org/2001/XMLSchema#string

P2860

Gene ontology: tool for the unification of biology

Cdc42 interaction with N-WASP and Toca-1 regulates membrane tubulation, vesicle formation and vesicle motility: implications for endocytosis

KEGG Atlas mapping for global analysis of metabolic pathways

Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1

WebGestalt: an integrated system for exploring gene sets in various biological contexts.

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.

Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus.

Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension.

P304

L474-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00202.2011

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P50

Daniel S Perrien

P577

2011-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22180660

http://www.w3.org/2001/XMLSchema#string

P921

P932

3311512

http://www.w3.org/2001/XMLSchema#string